AMRX
AMRX
NASDAQ · Pharmaceuticals

Amneal Pharmaceuticals Inc

$13.20
-0.52 (-3.79%)
As of May 9, 1:19 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +775.3% upside
Low Target $65.43
Average Target $115.54
High Target $156.42
Current Price $13.20
Current
$13.20
Target
$115.54
$65.43 $115.54 avg $156.42
Scenario Analysis
Bear Case
$65.43
395.7%
Low target
Base Case
$115.54
+775.3%
Avg target
Bull Case
$156.42
+1,085.0%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$15.42
-14.4% from high
52-Week Low
$7.02
+88.0% from low
50-Day SMA
$13.39
-1.4% vs SMA
200-Day SMA
$10.30
+28.2% vs SMA
RSI (14)
57.4
Neutral
Target vs 52W High
$115.54
+649.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%